Agreement signedPublished 17 Jul 2024
Ligand Pharmaceuticals Incorporated /
APEIRON Biologics AG
Ligand Pharmaceuticals Incorporated agrees to buy APEIRON Biologics AG
01 / BuyerLigand Pharmaceuticals Incorporated
02 / TargetAPEIRON Biologics AG
Source-verifiedWhat happened
Ligand Pharmaceuticals Incorporated agreed to acquire APEIRON Biologics AG for $100 million, according to a filing dated July 17, 2024.
The source
Everything on this page comes from the source below.
01
Source · Original source
Ligand Pharmaceuticals Incorporated agrees to buy APEIRON Biologics AG
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly